Multitask deep learning for prediction of microvascular invasion and recurrence-free survival in hepatocellular carcinoma based on MRI images [0.03%]
基于MRI图像的多任务深度学习在预测肝细胞癌的微血管侵犯和无复发生存中的应用
Fang Wang,Gan Zhan,Qing-Qing Chen et al.
Fang Wang et al.
Background and aims: Accurate preoperative prediction of microvascular invasion (MVI) and recurrence-free survival (RFS) is vital for personalised hepatocellular carcinoma (HCC) management. We developed a multitask deep l...
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma [0.03%]
经皮射频消融治疗肝内胆管细胞癌的长期肿瘤学疗效研究
Clémentine Alitti,Agnès Rode,Hervé Trillaud et al.
Clémentine Alitti et al.
Introduction: The effectiveness of percutaneous radiofrequency ablation (RFA) in intrahepatic cholangiocarcinomas (iCCA) remains insufficiently studied. M...
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma [0.03%]
阿特珠单抗和贝伐珠单抗治疗晚期肝细胞癌的进展模式及进展后生存分析
Satoshi Kobayashi,Taito Fukushima,Makoto Ueno et al.
Satoshi Kobayashi et al.
Background: Although the combination of atezolizumab and bevacizumab (ATZ + BEV) is a standard treatment for advanced hepatocellular carcinoma (HCC), strategies for addressing treatment failure and prognostic factors of p...
Global burden of acute hepatitis E between 1990 and 2019 and projections until 2030 [0.03%]
1990年至2019年以及截至2030年的急性戊型肝炎的全球疾病负担及预测
Guoqing Ouyang,Guangdong Pan,Qiuyun Li et al.
Guoqing Ouyang et al.
Background and aims: Acute hepatitis E (AHE) is still a public health issue worldwide. Here, we report the global burden of AHE in 204 countries and territories from 1990 to 2019 by age, sex and socio-demographic index (S...
Artificial replication cohort: Leveraging AI-fabricated data for genetic studies [0.03%]
人工智能复制队列：利用AI制造的数据进行遗传研究
Wiktor Smyk,Krystian Adrych,Marcin Krawczyk
Wiktor Smyk
Recent advancements in artificial intelligence (AI) present both opportunities and challenges within the scientific community. This study explores the capability of AI to replicate findings from genetic research, focusing on findings from p...
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort [0.03%]
血清PRO-C3有助于预测亚洲人群MAFLD合并慢性肾脏疾病的危险并评估纤维化程度
Liang-Jie Tang,Dan-Qin Sun,Sherlot Juan Song et al.
Liang-Jie Tang et al.
Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is an emerging risk factor for chronic kidney disease (CKD). N-terminal propeptide of collagen type 3 (PRO-C3) is a biomarker of advanced fibrosis i...
Martin S Schulz,Paolo Angeli,Jonel Trebicka
Martin S Schulz
In the traditional view, the occurrence of cirrhosis-related complications, such as hepatic encephalopathy, formation of ascites or variceal haemorrhage, marks the transition to the decompensated stage of cirrhosis. Although the dichotomous...
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma [0.03%]
抗乙肝病毒阳性肝细胞癌患者的特征和预后分析
Edoardo G Giannini,Andrea Pasta,Giulia Pieri et al.
Edoardo G Giannini et al.
Background & aims: Chronic hepatitis D virus (HDV) often leads to end-stage liver disease and hepatocellular carcinoma (HCC). Comprehensive data pertaining to large populations with HDV and HCC are missing, therefore we s...
Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development [0.03%]
APOB基因杂合突变与PNPLA3和TM6SF2变异的相互作用促进脂肪性肝病、肝硬化和HCC的发展
Yasmina Chouik,Mathilde Di Filippo,Sylvie Radenne et al.
Yasmina Chouik et al.
Inflammatory myofibroblastoma mimicking cavernous hemangioma in the liver [0.03%]
肝炎性肌纤维母细胞瘤与肝海绵状血管瘤鉴别一例
Hong Yang,Binglin Lai
Hong Yang
A 37-year-old female patient was admitted to the hospital with a large liver mass, diagnosed as hepatic inflammatory myofibroblastic tumour (HIMT), characterized by unique radiographic features and predominantly occurring in adults. HIMT co...